Human Fatty Liver Disease: Old Questions and New Insights

Nonalcoholic fatty liver disease (NAFLD) is a burgeoning health problem that affects one-third of adults and an increasing number of children in developed countries. The disease begins with the aberrant accumulation of triglyceride in the liver, which in some individuals elicits an inflammatory response that can progress to cirrhosis and liver cancer. Although NAFLD is strongly associated with obesity and insulin resistance, its pathogenesis remains poorly understood, and therapeutic options are limited. Here, we discuss recent mechanistic insights into NAFLD, focusing primarily on those that have emerged from human genetic and metabolic studies.

[1]  Jeffrey B. Schwimmer,et al.  Prevalence of Fatty Liver in Children and Adolescents , 2006, Pediatrics.

[2]  J. Goldstein,et al.  Selective versus total insulin resistance: a pathogenic paradox. , 2008, Cell metabolism.

[3]  B. Neuschwander‐Tetri,et al.  Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. , 2010, The New England journal of medicine.

[4]  N. Schork,et al.  Heritability of nonalcoholic fatty liver disease. , 2009, Gastroenterology.

[5]  Jonathan C. Cohen,et al.  A feed-forward loop amplifies nutritional regulation of PNPLA3 , 2010, Proceedings of the National Academy of Sciences.

[6]  S. Harrison,et al.  Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection , 2010, Hepatology.

[7]  J. Schneider,et al.  "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. , 2005, Cell metabolism.

[8]  A. Feldstein,et al.  Lipotoxicity in nonalcoholic fatty liver disease: not all lipids are created equal , 2009, Expert review of gastroenterology & hepatology.

[9]  Frank Eisenhaber,et al.  Fat Mobilization in Adipose Tissue Is Promoted by Adipose Triglyceride Lipase , 2004, Science.

[10]  R. Coleman,et al.  Hepatic triacylglycerol accumulation and insulin resistance This work was supported by National Institutes of Health Grants DK56598, DK59935, and DK56350. Published, JLR Papers in Press, November 6, 2008. , 2009, Journal of Lipid Research.

[11]  M. Welte.  Proteins under new management: lipid droplets deliver. , 2007, Trends in cell biology.

[12]  J. George,et al.  Animal models of nonalcoholic fatty liver disease , 2011, Nature Reviews Gastroenterology &Hepatology.

[13]  L. N. Valenti,et al.  Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: A role for insulin resistance and diabetes , 2008, Hepatology.

[14]  S. Caldwell,et al.  Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds. , 2000, The American journal of medicine.

[15]  Joseph L Goldstein,et al.  SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. , 2002, The Journal of clinical investigation.

[16]  Jonathan C. Cohen,et al.  Prevalence of hepatic steatosis in an urban population in the United States: Impact of ethnicity , 2004, Hepatology.

[17]  D. Reijngoud,et al.  Increased de novo Lipogenesis and Delayed Conversion of Large VLDL into Intermediate Density Lipoprotein Particles Contribute to Hyperlipidemia in Glycogen Storage Disease Type 1a , 2008, Pediatric Research.

[18]  M. Kumari,et al.  Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome[S] , 2011, Journal of Lipid Research.

[19]  P. Fontes,et al.  Recurrent disease following liver transplantation for nonalcoholic steatohepatitis cirrhosis , 2009, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[20]  Jonathan C. Cohen,et al.  Dissociation Between APOC3 Variants, Hepatic Triglyceride Content and Insulin Resistance , 2011, Hepatology.

[21]  S. Grundy,et al.  Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. , 2005, American journal of physiology. Endocrinology and metabolism.

[22]  S. Caldwell,et al.  Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. , 2009, Journal of hepatology.

[23]  S. Caldwell,et al.  Epidemiology and natural history of non-alcoholic steatohepatitis. , 2009, Clinics in liver disease.

[24]  John T. Melchior,et al.  CGI-58 knockdown in mice causes hepatic steatosis but prevents diet-induced obesity and glucose intolerance[S] , 2010, Journal of Lipid Research.

[25]  A. Kotronen,et al.  Unravelling the pathogenesis of fatty liver disease: patatin-like phospholipase domain-containing 3 protein , 2010, Current opinion in lipidology.

[26]  J. Burnett,et al.  Genetic determinants of hepatic steatosis in man , 2011, Journal of Lipid Research.

[27]  Alexander Pertsemlidis,et al.  Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease , 2008, Nature Genetics.

[28]  H. Tilg.  The Role of Cytokines in Non-Alcoholic Fatty Liver Disease , 2010, Digestive Diseases.

[29]  D. Yablonskiy,et al.  Fatty liver in familial hypobetalipoproteinemia: roles of the APOB defects, intra-abdominal adipose tissue, and insulin sensitivity. , 2004, Journal of lipid research.

[30]  A. Shapiro,et al.  Prevalence of hepatic steatosis after islet transplantation and its relation to graft function. , 2004, Diabetes.

[31]  A. Feldstein,et al.  Novel Insights into the Pathophysiology of Nonalcoholic Fatty Liver Disease , 2010, Seminars in liver disease.

[32]  J. George,et al.  Fitness versus fatness: Moving beyond weight loss in nonalcoholic fatty liver disease , 2010, Hepatology.

[33]  K. Petersen,et al.  Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease. , 2010, The New England journal of medicine.

[34]  B. Chang,et al.  Patatin‐like phospholipase domain‐containing 3/adiponutrin deficiency in mice is not associated with fatty liver disease , 2010, Hepatology.

[35]  S. Sookoian,et al.  A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity , 2009, Journal of Lipid Research.

[36]  J. Cercueil,et al.  Lack of an association between an apolipoprotein C3 genetic variant and the liver fat content in patients with type 2 diabetes , 2011, Hepatology.

[37]  Shijie Li,et al.  Bifurcation of insulin signaling pathway in rat liver: mTORC1 required for stimulation of lipogenesis, but not inhibition of gluconeogenesis , 2010, Proceedings of the National Academy of Sciences.

[38]  G. Hotamisligil,et al.  Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease , 2010, Cell.

[39]  David Kershenobich,et al.  Variant in PNPLA3 is associated with alcoholic liver disease , 2010, Nature Genetics.

[40]  T. Redgrave.  Formation of cholesteryl ester-rich particulate lipid during metabolism of chylomicrons. , 1970, The Journal of clinical investigation.

[41]  Claudio Cobelli,et al.  Increased prevalence of insulin resistance and nonalcoholic fatty liver disease in Asian-Indian men , 2006, Proceedings of the National Academy of Sciences.

[42]  K. Kasturi,et al.  Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis. , 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[43]  Luigi Ferrucci,et al.  Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. , 2008, American journal of human genetics.

[44]  S. O’Rahilly,et al.  Postreceptor insulin resistance contributes to human dyslipidemia and hepatic steatosis. , 2009, The Journal of clinical investigation.

[45]  L. Tappy,et al.  Metabolic effects of fructose and the worldwide increase in obesity. , 2010, Physiological reviews.

[46]  J. Repa,et al.  Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. , 2006, Cell metabolism.

[47]  Udo Hoffmann,et al.  Genome-Wide Association Analysis Identifies Variants Associated with Nonalcoholic Fatty Liver Disease That Have Distinct Effects on Metabolic Traits , 2011, PLoS genetics.

[48]  Nick V. Grishin,et al.  A Sequence Variation (I148M) in PNPLA3 Associated with Nonalcoholic Fatty Liver Disease Disrupts Triglyceride Hydrolysis , 2009, The Journal of Biological Chemistry.

[49]  J. Jessurun,et al.  Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. , 2005, The Journal of clinical investigation.

[50]  T. Saheki,et al.  Citrin deficiency as a cause of chronic liver disorder mimicking non-alcoholic fatty liver disease. , 2008, Journal of hepatology.